Tiocarlide: Difference between revisions

	WikiDoc Resources for Tiocarlide
Articles
Most recent articles on Tiocarlide Most cited articles on Tiocarlide Review articles on Tiocarlide Articles on Tiocarlide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Tiocarlide Images of Tiocarlide Photos of Tiocarlide Podcasts & MP3s on Tiocarlide Videos on Tiocarlide
Evidence Based Medicine
Cochrane Collaboration on Tiocarlide Bandolier on Tiocarlide TRIP on Tiocarlide
Clinical Trials
Ongoing Trials on Tiocarlide at Clinical Trials.gov Trial results on Tiocarlide Clinical Trials on Tiocarlide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Tiocarlide NICE Guidance on Tiocarlide NHS PRODIGY Guidance FDA on Tiocarlide CDC on Tiocarlide
Books
Books on Tiocarlide
News
Tiocarlide in the news Be alerted to news on Tiocarlide News trends on Tiocarlide
Commentary
Blogs on Tiocarlide
Definitions
Definitions of Tiocarlide
Patient Resources / Community
Patient resources on Tiocarlide Discussion groups on Tiocarlide Patient Handouts on Tiocarlide Directions to Hospitals Treating Tiocarlide Risk calculators and risk factors for Tiocarlide
Healthcare Provider Resources
Symptoms of Tiocarlide Causes & Risk Factors for Tiocarlide Diagnostic studies for Tiocarlide Treatment of Tiocarlide
Continuing Medical Education (CME)
CME Programs on Tiocarlide
International
Tiocarlide en Espanol Tiocarlide en Francais
Business
Tiocarlide in the Marketplace Patents on Tiocarlide
Experimental / Informatics
List of terms related to Tiocarlide

Tiocarlide
Clinical data
ATC code	J04AD02 (WHO) ;
Identifiers
	IUPAC name 1,3-bis[4-(3-methylbutoxy)phenyl]thiourea;
CAS Number	910-86-1 ;
PubChem CID	3001386;
ChemSpider	2272774 ;
UNII	43M23X81Y2;
ChEMBL	ChEMBL214920 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C23H32N2O2S
Molar mass	400.578 g/mol
3D model (JSmol)	Interactive image;
	SMILES S=C(Nc1ccc(OCCC(C)C)cc1)Nc2ccc(OCCC(C)C)cc2;
	InChI InChI=1S/C23H32N2O2S/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28) ; Key:BWBONKHPVHMQHE-UHFFFAOYSA-N ;
(what is this?) (verify)

← Older edit

Latest revision as of 17:17, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Thiocarlide (or tiocarlide or isoxyl) is a thiourea drug used in the treatment of tuberculosis, inhibiting synthesis of oleic acid and tuberculostearic acid.^[1]

Thiocarlide has considerable antimycobacterial activity in vitro and is effective against multi-drug resistant strains of Mycobacterium tuberculosis.^[2] Isoxyl inhibits M. bovis with six hours of exposure, which is similar to isoniazid and ethionamide, two other prominent anti-TB drugs. Unlike these two drugs, however, isoxyl also partially inhibits the synthesis of fatty acids.

Thiocarlide was developed by a Belgian company, Continental Pharma S.A. Belgo-Canadienne in Brussels, Belgium. The head researcher was Professor N. P. Buu-Hoi, head of Continental Pharma's Research Division.

References

↑ Phetsuksiri B, Jackson M, Scherman H; et al. (December 2003). "Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis". J. Biol. Chem. 278 (52): 53123–30. doi:10.1074/jbc.M311209200. PMID 14559907.
↑ Phetsuksiri B, Baulard AR, Cooper AM; et al. (May 1999). "Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis". Antimicrob. Agents Chemother. 43 (5): 1042–51. PMC 89109. PMID 10223912.

[1] Phetsuksiri B, Jackson M, Scherman H; et al. (December 2003). "Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis". J. Biol. Chem. 278 (52): 53123–30. doi:10.1074/jbc.M311209200. PMID 14559907.

[2] Phetsuksiri B, Baulard AR, Cooper AM; et al. (May 1999). "Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis". Antimicrob. Agents Chemother. 43 (5): 1042–51. PMC 89109. PMID 10223912.

[1]

[2]

v t e Antimycobacterials (J04)
Tuberculosis/ tuberculosis treatment	Aminosalicylic acid (Calcium aminosalicylate, Sodium aminosalicylate) Antibiotics (Amikacin, Capreomycin, Cycloserine, Kanamycin, Rifabutin, Rifampicin, Rifamycin, Rifapentin, Streptomycin) hydrazides (Isoniazid) thiocarbamides (Ethionamide, Protionamide, Tiocarlide) Others (Ethambutol, Morinamide, Pyrazinamide, Terizidone)
Leprosy	Aldesulfone sodium • Clofazimine • Dapsone • Rifampicin

Revision as of 15:48, 14 April 2015 view source Turky Alkathery (talk \| contribs) CMEUser, nocaptcha, Administrators 6,562 edits No edit summary ← Older edit	Latest revision as of 17:17, 20 August 2015 view source WikiBot (talk \| contribs) Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators 57,550 edits m Protected "Tiocarlide": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))
(No difference)

Clinical data


ATC code	J04AD02 (WHO)
Identifiers
IUPAC name 1,3-bis[4-(3-methylbutoxy)phenyl]thiourea
CAS Number	910-86-1^N
PubChem CID	3001386
ChemSpider	2272774^Y
UNII	43M23X81Y2
ChEMBL	ChEMBL214920^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₃H₃₂N₂O₂S
Molar mass	400.578 g/mol
3D model (JSmol)	Interactive image
SMILES S=C(Nc1ccc(OCCC(C)C)cc1)Nc2ccc(OCCC(C)C)cc2
InChI InChI=1S/C23H32N2O2S/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28)^Y Key:BWBONKHPVHMQHE-UHFFFAOYSA-N^Y
^NY (what is this?) (verify)

Tiocarlide: Difference between revisions

Latest revision as of 17:17, 20 August 2015

Overview

References

Navigation menu

Search